Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Isenberg

Showing results (501-510 of 519) with videos related to

Pageof 52
Sort By:
Journal of Autoimmunity|December 1, 1996
Interplay of four idiotypes and interaction with autoantibodies in lupus patients, their relatives and their spousesP Youinou, D A Isenberg, J K Kalsi, et al.
Annals of the Rheumatic Diseases|April 15, 2004
EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritisC-S Yee, C Gordon, C Dostal, et al.
Rheumatology (Oxford, England)|November 16, 2001
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathiesF W Miller, L G Rider, Y L Chung, et al.
Annals of the Rheumatic Diseases|May 24, 2007
BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000C-S Yee, D A Isenberg, A Prabu, et al.
The Journal of Rheumatology|November 28, 2000
Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study GroupA E Clarke, J Penrod, Y St Pierre, et al.
Rheumatology (Oxford, England)|April 9, 2005
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosusD A Isenberg, A Rahman, E Allen, et al.
Rheumatology (Oxford, England)|June 3, 2004
The systemic lupus erythematosus Tri-nation Study: absence of a link between health resource use and health outcomeA E Clarke, M Petri, S Manzi, et al.
Annals of the Rheumatic Diseases|April 18, 2002
Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre studyA G Tzioufas, R Wassmuth, U G Dafni, et al.
Rheumatology (Oxford, England)|November 23, 2007
Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndromeS J Bowman, N Sutcliffe, D A Isenberg, et al.
Rheumatology (Oxford, England)|June 6, 2008
The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndromeR J Barry, N Sutcliffe, D A Isenberg, et al.
Pageof 52

Showing results (501-510 of 519) with videos related to

Sort By:
Pageof 52
Journal of Autoimmunity|December 1, 1996
Interplay of four idiotypes and interaction with autoantibodies in lupus patients, their relatives and their spousesP Youinou, D A Isenberg, J K Kalsi, et al.
Annals of the Rheumatic Diseases|April 15, 2004
EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritisC-S Yee, C Gordon, C Dostal, et al.
Rheumatology (Oxford, England)|November 16, 2001
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathiesF W Miller, L G Rider, Y L Chung, et al.
Annals of the Rheumatic Diseases|May 24, 2007
BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000C-S Yee, D A Isenberg, A Prabu, et al.
The Journal of Rheumatology|November 28, 2000
Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study GroupA E Clarke, J Penrod, Y St Pierre, et al.
Rheumatology (Oxford, England)|April 9, 2005
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosusD A Isenberg, A Rahman, E Allen, et al.
Rheumatology (Oxford, England)|June 3, 2004
The systemic lupus erythematosus Tri-nation Study: absence of a link between health resource use and health outcomeA E Clarke, M Petri, S Manzi, et al.
Annals of the Rheumatic Diseases|April 18, 2002
Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre studyA G Tzioufas, R Wassmuth, U G Dafni, et al.
Rheumatology (Oxford, England)|November 23, 2007
Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndromeS J Bowman, N Sutcliffe, D A Isenberg, et al.
Rheumatology (Oxford, England)|June 6, 2008
The Sjögren's Syndrome Damage Index--a damage index for use in clinical trials and observational studies in primary Sjögren's syndromeR J Barry, N Sutcliffe, D A Isenberg, et al.
Pageof 52